Home > Insider Trading > Filing (0000899243-21-019445)

Filing Details

Accession Number:: 0000899243-21-019445
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-13 21:59:55
Reporting Period:: 2021-05-11

Accepted Time:: 2021-05-13 21:59:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1827506	Talaris Therapeutics Inc.	TALS	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1615352	Clarus Defined Exit I, L.p.	C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142	No	No	Yes	No
1619527	Clarus De Ii, L.p.	C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142	No	No	Yes	No
1700717	Clarus Iv-D, L.p.	C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142	No	No	Yes	No
1700718	Clarus Iv-C, L.p.	C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142	No	No	Yes	No
1700719	Clarus Iv-B, L.p.	C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142	No	No	Yes	No
1700720	Clarus Iv-A, L.p.	C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142	No	No	Yes	No
1793305	L.p. Gp Iv Clarus	C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142	No	No	Yes	No
1793316	L.l.c. Gp Clarus Blackstone	C/O The Blackstone Group Inc. 345 Park Avenue New York NY 10154	No	No	Yes	No
1857665	L.l.c. De Clarus Blackstone	C/O The Blackstone Group Inc. 345 Park Avenue New York NY 10154	No	No	Yes	No
1857754	Clarus Ventures De Gp, L.p.	C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-05-11	4,859,812	$0.00	4,859,812	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	690,150	$0.00	690,150	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	276,060	$0.00	276,060	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	557,546	$0.00	557,546	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	363,433	$0.00	363,433	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	670,347	$0.00	670,347	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	134,047	$0.00	134,047	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	130,236	$0.00	820,386	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	52,094	$0.00	328,154	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	105,213	$0.00	662,759	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	68,582	$0.00	432,015	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	126,499	$0.00	796,846	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	25,296	$0.00	159,343	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	15,918	$17.00	4,875,730	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	3,611	$17.00	823,997	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	1,444	$17.00	329,598	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	2,917	$17.00	665,676	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	1,902	$17.00	433,917	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	3,507	$17.00	800,353	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2021-05-11	701	$17.00	160,044	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2021-05-11	26,000,000	$0.00	4,859,812	$0.00
Common Stock	Series A-1 Convertible Preferred Stock	Disposition	2021-05-11	3,692,307	$0.00	690,150	$0.00
Common Stock	Series A-1 Convertible Preferred Stock	Disposition	2021-05-11	1,476,924	$0.00	276,060	$0.00
Common Stock	Series A-1 Convertible Preferred Stock	Disposition	2021-05-11	2,982,874	$0.00	557,546	$0.00
Common Stock	Series A-1 Convertible Preferred Stock	Disposition	2021-05-11	1,944,371	$0.00	363,433	$0.00
Common Stock	Series A-1 Convertible Preferred Stock	Disposition	2021-05-11	3,586,364	$0.00	670,347	$0.00
Common Stock	Series A-1 Convertible Preferred Stock	Disposition	2021-05-11	717,160	$0.00	134,047	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2021-05-11	696,767	$0.00	130,236	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2021-05-11	278,707	$0.00	52,094	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2021-05-11	562,891	$0.00	105,213	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2021-05-11	366,918	$0.00	68,582	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2021-05-11	676,774	$0.00	126,499	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2021-05-11	135,334	$0.00	25,296	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of the Issuer's Series A Convertible Preferred Stock, Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted on a 1-for-5.35 basis into common stock of the Issuer upon the closing of the Issuer's initial public offering.
Reflects securities held directly by Clarus Lifesciences III, L.P. Clarus Ventures III GP, L.P. is the general partner of Clarus Lifesciences III, L.P. Blackstone Clarus III L.L.C. is the general partner of Clarus Ventures III GP, L.P. The sole member of Blackstone Clarus III L.L.C. is Blackstone Holdings II L.P.
Reflects securities held directly by Clarus Defined Exit I, L.P.
Reflects securities held directly by Clarus DE II, L.P.
Reflects securities held directly by Clarus IV-A, L.P.
Reflects securities held directly by Clarus IV-B, L.P.
Reflects securities held directly by Clarus IV-C, L.P.
Reflects securities held directly by Clarus IV-D, L.P.
Clarus Ventures DE GP, L.P. is the general partner of each of Clarus Defined Exit I, L.P. and Clarus DE II, L.P. Blackstone Clarus DE L.L.C. is the general partner of Clarus Ventures DE GP, L.P. The sole member of Blackstone Clarus DE L.L.C. is Blackstone Holdings II L.P.
Clarus IV GP, L.P. is the general partner of each of Clarus IV-A, L.P., Clarus IV-B, L.P., Clarus IV-C, L.P. and Clarus IV-D, L.P. Blackstone Clarus GP L.P. is the general partner of Clarus IV GP, L.P. Blackstone Clarus GP L.L.C. is the general partner of Blackstone Clarus GP L.P. The sole member of Blackstone Clarus GP L.L.C. is Blackstone Holdings I L.P.
The general partner of each of Blackstone Holdings I L.P. and Blackstone Holdings II L.P. is Blackstone Holdings I/II GP L.L.C. The sole member of Blackstone Holdings I/II GP L.L.C. is The Blackstone Group Inc. The sole holder of the Series II preferred stock of The Blackstone Group Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.
Due to the limitations of the electronic filing system certain Reporting Persons are filing a separate Form 3.
Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.
Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.